Netherlands· NL-38266e9474ca

Taloxa-TABS 600 mg tabletten

A felbamate product containing felbamaat, registered in Netherlands by Medcor Pharmaceuticals B.V.. The same ATC class is registered in 9 of our 19 countries.

ATC N03AX10

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about felbamaatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Felbamate is registered in 9 of 19 countries.

Countries holding a registration under ATC N03AX10 (felbamate), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
6 of them publish a price we can compare per daily dose

Search felbamate products by name

Felbamate · ATC N03AX10

9 / 19 countries

Belgiumprice
Franceprice
Germany
Italyprice
Netherlands
Norwayprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of felbamate costs, country by country.

Normalised to the WHO defined daily dose (2.4 g), the median price runs from $4.40 in United States to $10.58 in Switzerland — a ×2.4 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Felbamate · price per daily dose (2.4 g)

USD · FX 28 Sept 2026

CH Switzerland$10.58
IT Italy$9.01
US United States$4.40 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: FELBAMAAT
Manufacturer: Medcor Pharmaceuticals B.V.
Country: Netherlands (NL)
ATC code: N03AX10
ATC class: Felbamate
Defined daily dose: 2.4 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
134703//110909

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

267 interactions on record for felbamate.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check felbamate against other medicines How interaction checks work

Felbamate · interactions on record

267 records

12 severe
221 moderate
7 minor

Most severe, free to view

Levonorgestrel and ethinylestradiolG03AA07severe
Desogestrel and ethinylestradiolG03AA09severe
Drospirenone and ethinylestradiolG03AA12severe
EthinylestradiolG03CA01severe

27 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Felbamate in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All felbamate products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

Austria · Taloxa
Belgium · Taloxa-Susp, Taloxa-Tabs
Germany · Taloxa, Taloxa Saft
France · Taloxa
Hungary · Taloxa
Italy · Taloxa
Luxembourg · Taloxa-Susp, Taloxa-Tabs
Norway · Taloxa
Portugal · Taloxa
Sweden · Taloxa

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/8057ac03-43c7-4276-b677-fa210e600ba6
GET /v1/drugs/8057ac03-43c7-4276-b677-fa210e600ba6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h110909_smpc.pdf",
  "strength": null,
  "atc_label": "Felbamate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg134703",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "ZETMEEL, GEPREGELATINEERD"
  ],
  "substances": [
    "FELBAMAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h134703.pdf",
  "authorised_at": "2025/03/26",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "134703//110909",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about felbamate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console